4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
NanoRepro AG (NN6) operates in the Diagnostics & Research industry and is headquartered in Marburg, Germany with about 22 employees. Its market capitalization is roughly €22 million. In the fiscal year ended 2024-12-31, NN6 reported €5M in revenue and (€2M) in net income.
NanoRepro AG engages in the development, manufacture, and distribution of rapid diagnostic tests and food supplements for home and professional use in Germany and internationally.
Interactive charts & full statements →
| Income statement | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Revenue | €5M | €3M | €39M | €163M |
| Gross Profit | €3M | €2M | €12M | €57M |
| Operating Income (EBIT) | (€4M) | (€4M) | €6M | €40M |
| Net Income | (€2M) | (€5M) | (€4M) | €30M |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Dividends Paid | — | (€2M) | (€6M) | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Assets | €39M | €42M | €50M | €79M |
| Total Liabilities | €1M | €1M | €2M | €22M |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NN6 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms